TR200200434T2 - Yeni makrolit antibiyotikler. - Google Patents

Yeni makrolit antibiyotikler.

Info

Publication number
TR200200434T2
TR200200434T2 TR2002/00434T TR200200434T TR200200434T2 TR 200200434 T2 TR200200434 T2 TR 200200434T2 TR 2002/00434 T TR2002/00434 T TR 2002/00434T TR 200200434 T TR200200434 T TR 200200434T TR 200200434 T2 TR200200434 T2 TR 200200434T2
Authority
TR
Turkey
Prior art keywords
macrolide antibiotics
new macrolide
infections
antibiotics
antiprotozoal
Prior art date
Application number
TR2002/00434T
Other languages
English (en)
Inventor
Kaneko Takushi
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200200434T2 publication Critical patent/TR200200434T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Bu bulus,a,R1,R2,R3,R4,R5,R6 ve X'ten her birinin yukarida tanimlandigi gibi oldugu formül (I)'e ait bilesiklerle, ve bunlarin,çesitli bakteriyel ve protozoal enfeksiyonlari ve bu enfeksiyonlara bagli bozukluklari tedavi etmek için kullanilabilen potansiyel antibakteriyel ve antiprotozoal maddeler olarak faydali farmasötik açidan kabul gören tuzlari ile ilgilidir.Bulus ayrica formül (I)'e ait bilesikleri ihtiva eden farmasötik kompozisyonlarla ve formül (I)'e bilesiklerin uygulanmasi suretiyle bakteriyel ve protozoal enfeksiyonlarin tedavisi edilmesine yönelik metotlarla da ilgilidir.
TR2002/00434T 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler. TR200200434T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10683698P 1998-11-03 1998-11-03

Publications (1)

Publication Number Publication Date
TR200200434T2 true TR200200434T2 (tr) 2002-09-23

Family

ID=22313524

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2002/00434T TR200200434T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler.
TR2001/01241T TR200101241T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler
TR2002/00436T TR200200436T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler
TR2002/00435T TR200200435T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler.

Family Applications After (3)

Application Number Title Priority Date Filing Date
TR2001/01241T TR200101241T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler
TR2002/00436T TR200200436T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler
TR2002/00435T TR200200435T2 (tr) 1998-11-03 1999-10-18 Yeni makrolit antibiyotikler.

Country Status (34)

Country Link
US (3) US20020040007A1 (tr)
EP (1) EP1124837A2 (tr)
JP (1) JP4043191B2 (tr)
KR (1) KR20010083944A (tr)
CN (1) CN1376160A (tr)
AP (1) AP2001002131A0 (tr)
AU (1) AU5995299A (tr)
BG (1) BG105543A (tr)
BR (1) BR9914998A (tr)
CA (1) CA2349338C (tr)
CO (1) CO5140110A1 (tr)
CZ (1) CZ20011512A3 (tr)
EA (1) EA200100396A1 (tr)
EE (1) EE200100245A (tr)
GT (1) GT199900192A (tr)
HK (1) HK1049010A1 (tr)
HR (1) HRP20010306A2 (tr)
HU (1) HUP0104192A3 (tr)
ID (1) ID28286A (tr)
IL (1) IL142628A0 (tr)
IS (1) IS5919A (tr)
MA (1) MA26703A1 (tr)
NO (1) NO20012155L (tr)
OA (1) OA11670A (tr)
PA (1) PA8485101A1 (tr)
PE (1) PE20001289A1 (tr)
PL (1) PL348114A1 (tr)
SK (1) SK5812001A3 (tr)
SV (1) SV1999000188A (tr)
TN (1) TNSN99205A1 (tr)
TR (4) TR200200434T2 (tr)
UY (1) UY25780A1 (tr)
WO (1) WO2000026224A2 (tr)
ZA (1) ZA200103289B (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
JP4043191B2 (ja) 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
HUP0105190A3 (en) 1999-01-27 2003-03-28 Pfizer Prod Inc Ketolide antibiotics, medicaments containing them and their use
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
CN1351608A (zh) 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
EP1167376B1 (en) * 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
PT1836211E (pt) 2004-12-21 2010-04-08 Pfizer Prod Inc Macrólidos
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
US8409628B2 (en) 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
WO2011123619A2 (en) 2010-03-31 2011-10-06 Penguin Ip Holdings Inc. Permeable mixtures, methods and compositions for the skin
AU2014262127B2 (en) * 2013-05-01 2019-05-02 Neoculi Pty Ltd Methods for treating bacterial infections
RU2537143C1 (ru) * 2013-11-08 2014-12-27 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства РАСХН Препарат для лечения и профилактики мастита у коров
WO2018080072A2 (ko) * 2016-10-27 2018-05-03 한국생명공학연구원 신규한 매크로라이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 말라리아의 예방 또는 치료용 약학적 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2697524B1 (fr) 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
HRP950145A2 (en) * 1995-03-27 1997-08-31 Sour Pliva New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
JP2000509712A (ja) 1996-05-07 2000-08-02 アボツト・ラボラトリーズ ６―ｏ―置換エリスロマイシン及びその製造方法
EE03976B1 (et) 1996-07-05 2003-02-17 Biotica Technology Limited Erütromütsiinid ja nende valmistamise meetod
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
KR100523679B1 (ko) 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-ｏ-치환된 케톨라이드
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) * 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
WO1999020639A2 (en) 1997-10-16 1999-04-29 Pliva, Farmaceutska Industrija ,Dionicko, Drustvo NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
PT941998E (pt) * 1998-03-03 2004-12-31 Pfizer Prod Inc Antibioticos macrolidos do tipo 3,6-cetal
JP4043191B2 (ja) 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
CN1351608A (zh) 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
EP1114826A3 (en) 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1122261A3 (en) 2000-01-31 2001-09-26 Pfizer Products Inc. 13 and 14-membered antibacterial macrolides
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
WO2003004509A2 (en) 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity

Also Published As

Publication number Publication date
ZA200103289B (en) 2002-08-28
BR9914998A (pt) 2001-07-10
SK5812001A3 (en) 2001-12-03
HRP20010306A2 (en) 2002-06-30
PA8485101A1 (es) 2002-08-26
US20050004047A1 (en) 2005-01-06
WO2000026224A2 (en) 2000-05-11
GT199900192A (es) 2001-04-26
CN1376160A (zh) 2002-10-23
US6835716B2 (en) 2004-12-28
UY25780A1 (es) 2001-08-27
HK1049010A1 (zh) 2003-04-25
AU5995299A (en) 2000-05-22
KR20010083944A (ko) 2001-09-03
EE200100245A (et) 2002-10-15
CO5140110A1 (es) 2002-03-22
BG105543A (en) 2001-12-29
HUP0104192A2 (hu) 2002-02-28
OA11670A (en) 2005-01-12
CA2349338A1 (en) 2000-05-11
EA200100396A1 (ru) 2001-10-22
CA2349338C (en) 2005-12-06
PE20001289A1 (es) 2000-11-22
ID28286A (id) 2001-05-10
TR200200435T2 (tr) 2002-07-22
SV1999000188A (es) 2000-10-16
NO20012155L (no) 2001-07-02
TR200101241T2 (tr) 2001-09-21
HUP0104192A3 (en) 2003-12-29
TR200200436T2 (tr) 2002-06-21
US20030013665A1 (en) 2003-01-16
MA26703A1 (fr) 2004-12-20
NO20012155D0 (no) 2001-05-02
JP4043191B2 (ja) 2008-02-06
AP2001002131A0 (en) 2001-06-30
WO2000026224A3 (en) 2000-11-16
IS5919A (is) 2001-04-17
US7071170B2 (en) 2006-07-04
US20020040007A1 (en) 2002-04-04
JP2002528553A (ja) 2002-09-03
IL142628A0 (en) 2002-03-10
CZ20011512A3 (cs) 2001-09-12
EP1124837A2 (en) 2001-08-22
TNSN99205A1 (fr) 2005-11-10
PL348114A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
TR200200434T2 (tr) Yeni makrolit antibiyotikler.
BR9914221A (pt) Derivados de glicopeptìdeos e composições farmacêuticas contendo os mesmos
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
NO834146L (no) Fremgangsmaate for fremstilling av epimert azahomoerytromycin a
EA200100623A1 (ru) Кетолидные антибиотики
MY128650A (en) Benzoxazine antimicrobial agents
TR199902995T2 (tr) 9-Oksim eritromisin türevleri
EA200400701A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
ES2159733T3 (es) Compuestos de dialquiltiacumicina.
ES2161344T3 (es) Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.
TR200003250T2 (tr) Higromisin A türevleri
ATE250610T1 (de) Kaliumkanal-blockierende mittel
ATE223226T1 (de) Azazyklohexapeptid-verbindungen
CA2351829A1 (en) Macrolide antibiotics
TR200003249T2 (tr) 2''-Deoksi higromisin türevleri
TR200201145T2 (tr) Hidromisin türevleri
MX9804955A (es) Antibioticos hidrosolubles.
TR199902820T2 (tr) Multisiklik eritromisin türevleri.
TR21967A (tr) Organo-kalay bilesikleri